Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.

ABSTRACT:

Importance

Genetic studies of Alzheimer disease have focused on the clinical or pathologic diagnosis as the primary outcome, but little is known about the genetic basis of the preclinical phase of the disease.

Objective

To examine the underlying genetic basis for brain amyloidosis in the preclinical phase of Alzheimer disease.

Design, setting, and participants

In the first stage of this genetic association study, a meta-analysis was conducted using genetic and imaging data acquired from 6 multicenter cohort studies of healthy older individuals between 1994 and 2019: the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease Study, the Berkeley Aging Cohort Study, the Wisconsin Registry for Alzheimer's Prevention, the Biomarkers of Cognitive Decline Among Normal Indi

SUBMITTER: Raghavan NS 

PROVIDER: S-EPMC7309575 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature